New Student Offer- Use Code HELLO

Register Now

China's Ad5-nCoV Vaccine

Published on September 06, 2022
Current Context: China's CanSino Biologics Inc. developed the world's first needle-free COVID-19 Vaccine which can be inhaled.
China's Ad5-nCoV Vaccine
  • CanSino’s Ad5-nCoV Vaccine was given approval by China’s National Medical Products Administration for emergency use as a booster vaccine.
  • Ad5-nCoV is the latest version of CanSino’s one-shot Covid drug which was used by China, Pakistan, Hungary, Mexico, and Malaysia after it was rolled out in February 2021.
  • CanSino said that the inhaled version of the vaccine will trigger cellular immunity by stimulating antibodies in nasal and airway tissues to defend against COVID-19.
  • Many companies around the globe are researching the possibility of needle-free vaccines for other preventable diseases as they could appeal to vaccine-hesitant people.
  • Covaxin is only India's indigenous COVID-19 vaccine which was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).


Q.1 The world's first inhaled version of the COVID-19 vaccine has been developed by?
a. China
b. India
c. Germany
d. USA

Can I help you?

ramandeep singh

Hey I am Ramandeep Singh. I am determined to help students preparing for RBI, SEBI, NABARD and IBPS exams. Do you want me to help you ?

Join my class here
    Follow me:
Close Menu
Close Menu